rs6009961
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001097.3(ACR):c.566-4A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.708 in 1,482,114 control chromosomes in the GnomAD database, including 387,615 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001097.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACR | NM_001097.3 | c.566-4A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000216139.10 | NP_001088.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACR | ENST00000216139.10 | c.566-4A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001097.3 | ENSP00000216139 | P1 |
Frequencies
GnomAD3 genomes AF: 0.737 AC: 111259AN: 150872Hom.: 41911 Cov.: 26
GnomAD3 exomes AF: 0.657 AC: 161125AN: 245076Hom.: 54934 AF XY: 0.653 AC XY: 86473AN XY: 132516
GnomAD4 exome AF: 0.705 AC: 938035AN: 1331128Hom.: 345657 Cov.: 31 AF XY: 0.699 AC XY: 465895AN XY: 666922
GnomAD4 genome AF: 0.738 AC: 111370AN: 150986Hom.: 41958 Cov.: 26 AF XY: 0.728 AC XY: 53684AN XY: 73694
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 66% of total chromosomes in ExAC - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at